Terms: = Lung cancer AND BRIP1, MGC126521, 83990, ENSG00000136492, FANCJ, FLJ90232, Q9BX63, MGC126523, OF
1615 results:
1. Neoadjuvant immune checkpoint blockade enhances local and systemic tumor immunity in head and neck cancer.
Zhao Y; Wucherpfennig KW
Curr Opin Oncol; 2024 May; 36(3):136-142. PubMed ID: 38573202
[TBL] [Abstract] [Full Text] [Related]
2. Gut microbiota-dependent modulation of pre-metastatic niches by Jianpi Yangzheng decoction in the prevention of lung metastasis of gastric cancer.
Zhu X; Zhang X; Shen J; Zheng S; Li H; Han B; Zhang C; Chen M; Sun Q; Wu J
Phytomedicine; 2024 Jun; 128():155413. PubMed ID: 38513377
[TBL] [Abstract] [Full Text] [Related]
3. Antiproliferative and immunomodulative potential of Citrullus colocynthis and its bioactive compounds in human lymphocytes and lung cells.
Stein C; Voigts J; Niederreiter L; Kowarschik S; Huber R; Lüth VM
J Ethnopharmacol; 2024 Jun; 328():118053. PubMed ID: 38499257
[TBL] [Abstract] [Full Text] [Related]
4. Thai traditional medicines reduce CD147 levels in lung cells: Potential therapeutic candidates for cancers, inflammations, and COVID-19.
Sukadeetad K; Sripanidkulchai B; Tangsukworakhun S; Payomchuen R; Sakulchatrungroj A; Supmoon S; Punkvang A
J Ethnopharmacol; 2024 Jun; 327():118042. PubMed ID: 38493907
[TBL] [Abstract] [Full Text] [Related]
5. Adjuvant treatment with Cordyceps sinensis for lung cancer: A systematic review and meta-analysis of randomized controlled trials.
Wang C; Wang J; Qi Y
J Ethnopharmacol; 2024 Jun; 327():118044. PubMed ID: 38484953
[TBL] [Abstract] [Full Text] [Related]
6. Physical activity for cancer prehabilitation: A scoping review.
Yang L; Alice A; Friedenreich CM
Crit Rev Oncol Hematol; 2024 Apr; 196():104319. PubMed ID: 38460927
[TBL] [Abstract] [Full Text] [Related]
7. Printing of 3D biomimetic structures for the study of bone metastasis: A review.
Khanmohammadi M; Volpi M; Walejewska E; Olszewska A; Swieszkowski W
Acta Biomater; 2024 Apr; 178():24-40. PubMed ID: 38458512
[TBL] [Abstract] [Full Text] [Related]
8. Definitions, outcomes and perspectives for oligometastatic bladder cancer: towards a standardized terminology.
Calleris G; von Deimling M; Kesch C; Soria F; Gontero P; Ploussard G; Laukhtina E; Pradere B
Curr Opin Urol; 2024 May; 34(3):217-224. PubMed ID: 38426242
[TBL] [Abstract] [Full Text] [Related]
9. Integrating serum pharmacochemistry and network pharmacology to explore the molecular mechanisms of Acanthopanax senticosus (Rupr. & Maxim.) Harms on attenuating doxorubicin-induced myocardial injury.
Zhang X; Zhang Q; Yu M; Zhang Y; He T; Qiu Z; Qiu Y; Wang W
J Ethnopharmacol; 2024 Jan; 319(Pt 3):117349. PubMed ID: 38380572
[TBL] [Abstract] [Full Text] [Related]
10. Three dimensional fibrotic extracellular matrix directs microenvironment fiber remodeling by fibroblasts.
Nizamoglu M; Alleblas F; Koster T; Borghuis T; Vonk JM; Thomas MJ; White ES; Watson CK; Timens W; El Kasmi KC; Melgert BN; Heijink IH; Burgess JK
Acta Biomater; 2024 Mar; 177():118-131. PubMed ID: 38350556
[TBL] [Abstract] [Full Text] [Related]
11. Geographical Disparities in lung cancer in Canada: A Review.
Yousefi J
Curr Oncol Rep; 2024 Mar; 26(3):221-235. PubMed ID: 38319507
[TBL] [Abstract] [Full Text] [Related]
12. Systemic platelet inhibition with localized chemotherapy by an injectable ROS-scavenging gel against postsurgical breast cancer recurrence and metastasis.
Gui J; Zhu Y; Chen X; Gong T; Zhang Z; Yu R; Fu Y
Acta Biomater; 2024 Mar; 177():388-399. PubMed ID: 38307476
[TBL] [Abstract] [Full Text] [Related]
13. Incidental Diagnosis of Left Pneumothorax Using a New Variant of the lung Point Sign During Cardiac Ultrasound.
Cheong I; Bermeo M; Tamagnone FM; Merlo PM
J Emerg Med; 2024 Mar; 66(3):e354-e356. PubMed ID: 38267299
[TBL] [Abstract] [Full Text] [Related]
14. From the Breast to the Finger - A Case Report of Acrometastasis.
Ita IO; Mustapha B; Adesunkanmi AO; Aderounmu AA; Adefidipe AA; Aderibigbe AS; Wuraola FO
West Afr J Med; 2023 Dec; 40(12):1383-1386. PubMed ID: 38266227
[TBL] [Abstract] [Full Text] [Related]
15. Gene Therapy Versus Common Care for Eligible Individuals With Sickle Cell Disease in the United States : A Cost-Effectiveness Analysis.
Basu A; Winn AN; Johnson KM; Jiao B; Devine B; Hankins JS; Arnold SD; Bender MA; Ramsey SD
Ann Intern Med; 2024 Feb; 177(2):155-164. PubMed ID: 38252942
[TBL] [Abstract] [Full Text] [Related]
16. Nanoparticle-integrated dissolving microneedles for the co-delivery of R848/aPD-1 to synergistically reverse the immunosuppressive microenvironment of triple-negative breast cancer.
Huang S; Wen T; Wang J; Wei H; Xiao Z; Li B; Shuai X
Acta Biomater; 2024 Mar; 176():344-355. PubMed ID: 38244662
[TBL] [Abstract] [Full Text] [Related]
17. Life Expectancy After Treatment of Metastatic Bone Disease: An International Trend Analysis.
Rogers DL; Raad M; Rivera JA; Wedin R; Laitinen M; Sørensen MS; Petersen MM; Hilton T; Morris CD; Levin AS; Forsberg JA
J Am Acad Orthop Surg; 2024 Mar; 32(6):e293-e301. PubMed ID: 38241634
[TBL] [Abstract] [Full Text] [Related]
18. Healthcare providers' perspectives on implementing a brief physical activity and diet intervention within a primary care smoking cessation program: a qualitative study.
Minian N; Mehra K; Lingam M; Dragonetti R; Veldhuizen S; Zawertailo L; deRuiter WK; Melamed OC; Moineddin R; Thorpe KE; Taylor VH; Hahn M; Selby P
BMC Prim Care; 2024 Jan; 25(1):16. PubMed ID: 38184559
[TBL] [Abstract] [Full Text] [Related]
19. Stage 3 N2 lung cancer: A Multidisciplinary Therapeutic Conundrum.
Carter L; Apte V; Shukla A; Ghose A; Mamidi R; Petohazi A; Makker S; Banerjee S; Boussios S; Banna GL
Curr Oncol Rep; 2024 Jan; 26(1):65-79. PubMed ID: 38180692
[TBL] [Abstract] [Full Text] [Related]
20. Measured Steps: Navigating the Path of Oligoprogressive lung cancer with Targeted and Immunotherapies.
Jongbloed M; Khosla AA; Bartolomeo V; Jatwani K; Singh R; De Ruysscher DKM; Hendriks LEL; Desai A
Curr Oncol Rep; 2024 Jan; 26(1):80-89. PubMed ID: 38175464
[TBL] [Abstract] [Full Text] [Related]
[Next]
